Clinical Trials Logo

Opiate Addiction clinical trials

View clinical trials related to Opiate Addiction.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT03583138 Completed - Clinical trials for Human Immunodeficiency Virus

HIV, Buprenorphine, and the Criminal Justice System (STRIDE2)

Start date: June 23, 2014
Phase:
Study type: Observational

STRIDE2 is a longitudinal, non-randomized study of individuals living with HIV who are dependent on opioids. This study is funded by the National Institute on Drug Abuse (R01DA030768, Altice, PI; Taxman & Lawson, Co-PIs) and is being conducted by George Mason University, Yale University, and Howard University.

NCT ID: NCT03278496 Completed - Opiate Addiction Clinical Trials

Recovery Housing and Drug Abuse Treatment Outcome

Start date: April 2001
Phase: N/A
Study type: Interventional

Reinforcement-Based Therapy (RBT) is an intensive outpatient substance abuse treatment that includes relapse prevention skills training, goal setting, help with finding employment and abstinence-contingent rent payment for recovery housing in the community. It is meant to provide motivation for continued abstinence while enhancing social stability. In this study, treatment was offered to inner city opiate and cocaine users immediately following a brief medically-supported residential detoxification. Previous research had shown that RBT produces 3- month outcomes superior to those for patients who are referred to outpatient treatment in the community. The present study compared outcomes for patients (N = 243) randomly assigned to receive abstinence-contingent recovery housing with (full RBT) or without additional intensive counseling or to receive usual care referral to outpatient treatment following detoxification. Outcomes were similar at 3- and 6-month follow-ups for those who received recovery housing with (full RBT) and without additional counseling and both these treatments were superior to usual care referral. Study findings support the efficacy of post-detoxification recovery housing with or without counseling for opiate and cocaine users.

NCT ID: NCT03150173 Completed - Opiate Addiction Clinical Trials

Onsite Buprenorphine Treatment at Syringe Exchange Programs

O-BMT
Start date: January 2, 2019
Phase: Phase 2
Study type: Interventional

This trial will recruit syringe exchange participants with opioid use disorder in New York City and test whether starting buprenorphine treatment at the syringe exchange program is more effective than referral to a community health center for buprenorphine treatment.

NCT ID: NCT03015597 Completed - Smoking Cessation Clinical Trials

Pilot Study of Contingency Management for Smoking Cessation

Start date: October 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to see whether contingency management (CM) can be successfully added as an adjunct treatment to standard stop smoking services in outpatients undergoing treatment for opiate addiction. Forty tobacco smoking patients undergoing treatment for opiate addiction will be stratified to a CM intervention for either smoking abstinence or attendance at the clinic, whilst also receiving usual stop smoking services cessation treatment. The intervention will run for five weeks and participants will be followed up six months after the beginning of the study.

NCT ID: NCT02997644 Completed - Opiate Addiction Clinical Trials

Impact of Different Educational Approaches on Post-operative Opiate Utilization After Elective Lower Extremity Surgery

OpiateLEO
Start date: June 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the use of post-operative opioid use after two different educational interventions. The investigators will compare changes in pain, disability and sleep between groups 6 months after elective lower extremity surgery.

NCT ID: NCT02863601 Completed - Pregnancy Clinical Trials

Impact of Pregnancy on Buprenorphine Pharmacokinetics and Pharmacodynamics

Start date: August 2016
Phase:
Study type: Observational

The primary purpose of this study is to determine whether buprenorphine and metabolite exposure (reflected as the dose-adjusted plasma concentration x time curve [AUC]) differs during pregnancy and between pregnancy and the postpartum state.The study will define the pharmacokinetics of buprenorphine and determine if there is a better way to gauge dosing based on objective, physiological parameters of satiety. The study will define neonatal exposure to buprenorphine through breast milk.

NCT ID: NCT02801357 Completed - Opiate Dependence Clinical Trials

Study to Evaluate the Exposures of Lofexidine and Its Major Metabolites in Subjects Seeking Buprenorphine Dose Reduction

Start date: June 2016
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the relative exposures of lofexidine and its major metabolites in subjects seeking buprenorphine dose reduction.

NCT ID: NCT02678507 Completed - Clinical trials for Opioid-Related Disorders

A Quantitative Study to Assess the Construct Validity of the Prescription Opioid Misuse and Abuse Questionnaire

POMAQ
Start date: April 7, 2015
Phase:
Study type: Observational

The purposes of this study are to evaluate the validity and reproducibility of the POMAQ to identify opioid abuse and misuse behaviors among participants who have chronic pain which requires long-term opioid use.

NCT ID: NCT02674711 Completed - Low Back Pain Clinical Trials

Study of Opioid Use After Lumbar and Cervical Spine Surgery

SOULCS
Start date: August 2015
Phase: N/A
Study type: Interventional

The purpose of this project is to assess the impact of an educational video on the use of prescription opioid medication during a 6-month period following spine surgery. Subjects will be recruited from the pool of patients coming in for the pre-operative appointment prior to spine surgery. Patients that consent and enroll will be randomized to receive either a brief educational video at this appointment or usual care. Patients will be followed after surgery weekly for the first month, and then again at 6 months to determine their prescription opioid medication utilization patterns. Prescription data will also be pulled from electronic medical records.

NCT ID: NCT02668549 Completed - Clinical trials for Opioid-Related Disorders

Cross-Sectional Study to Define and Validate "Doctor/Pharmacy Shopping" as Outcomes Suggestive of Abuse and/or Addiction

Start date: February 5, 2015
Phase:
Study type: Observational

The purpose of this study is to formulate definitions of doctor/pharmacy shopping and evaluate its association with abuse/addiction